WuXi Biologics earns sixth straight FTSE4Good inclusion, highlighting its green CRDMO sustainability leadership
Executive summary: WuXi Biologics announced its inclusion in the FTSE4Good Index Series for the sixth consecutive year, based on its green CRDMO sustainability performance. The continued ESG recognition can attract sustainability‑focused investors, improve the company's reputation and potentially lower its cost of capital.
Who is involved: WuXi Biologics (ticker 2269.HK) and FTSE Russell, which oversees the FTSE4Good Index Series.
Likely next: WuXi Biologics must maintain its ESG scores above FTSE4Good thresholds to retain the index inclusion in future annual reviews.
WuXi Biologics announced that FTSE Russell has kept it in the FTSE4Good Index Series for a sixth year in a row, citing the company's environmentally focused contract research, development and manufacturing operations. The recognition underscores the firm's sustained ESG performance and its value creation through greener CRDMO services. It places WuXi Biologics among a select group of companies meeting FTSE4Good's environmental, social and governance criteria.
Timeline
- — WuXi Biologics Recognized by FTSE4Good for the Sixth Consecutive Year, Underscoring Value Creation Through Green CRDMO (PR Newswire)
- — WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year (PR Newswire)
Analysis — what this means
Likely next events
- Bio-based material trends projected to influence fashion industry throughout 2027 (per Sorona® and WGSN announcement, July 2026)
Sectors affected
- Contract Research, Development, and Manufacturing Organization (CRDMO) industry
- Bio-based materials market (e.g., Sorona® polymer)
- FTSE4Good-indexed sustainable investment funds
Historical parallels
- WuXi AppTec secured FTSE4Good inclusion for the fourth consecutive year on July 22, 2026
Key entities
Sources
- WuXi Biologics Recognized by FTSE4Good for the Sixth Consecutive Year, Underscoring Value Creation Through Green CRDMO — PR Newswire
- WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year — PR Newswire
Related cases
- WuXi AppTec raises its 2026 interim dividend to RMB 1.51 billion, returning more cash to shareholders amid strong half‑year results
- WuXi Biologics earns top sustainable biopharma recognition, underscoring its green CRDMO leadership
- WuXi XDC’s GMP‑cleared BCM3 facility in Singapore expands its bioconjugate manufacturing capacity, positioning the CDMO to capture additional global contract work
- InfiMotion Technology debuts its E Drive electric propulsion system in Wuxi, signaling readiness for EV market engagement
- InfiMotion Technology’s public debut in Wuxi highlights its full E‑drive system capabilities and marks its entry as an independent electric‑vehicle drivetrain supplier
- WuXi AppTec's fourth straight year in the FTSE4Good Index highlights its sustained ESG leadership and may boost appeal to sustainability‑focused investors